Content embedded from external sources will not be displayed without your consent.
Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.
Medcram - Oct-13
Would eating a handful of walnuts reduce viral replication?
Coronavirus Update 112: Linoleic Acid; Vaccines; UK COVID 19 Data
Content embedded from external sources will not be displayed without your consent.
Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.
"The correlation between the ivermectin interventions and the decrease in both mortality and lethality are quite strong and consistent in all the regions analyzed. However, this correlation could have been caused by other factors or as a product of an accident...The bottom line: treatment with Ivermectin is the most reasonable explanation for the decrease in the number of deaths and the fatality rate in Peru....
Content embedded from external sources will not be displayed without your consent.
Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.
Drbeen Medical Lectures: Bromhexine Protocol Talk with Dr. Harrison
(Bromhexine available over the counter everywhere outside U.S. and online)
Content embedded from external sources will not be displayed without your consent.
Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.
COVID-19 ACUTE: TREATMENT WITH HIGH DOSES OF IVERMECTIN IN MODERATE,
SEVERE AND CRITICAL CASES. Table: DOSE OF IVERMECTINE ACCORDING TO
Content embedded from external sources will not be displayed without your consent.
Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.
Drbeen Medical Lectures - Green Tea (EGCG) Zinc Ionophores, Nasal Sprays, Kinin B2 Receptor Antagonists
Content embedded from external sources will not be displayed without your consent.
Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.
Content embedded from external sources will not be displayed without your consent.
Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.
COVID19-Ivermectin Frontline Care Dr Landrito in the Philippines Saving Lives-Pandemic Protection?
Content embedded from external sources will not be displayed without your consent.
Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.
Volunteers in Moderna's and Pfizer's coronavirus vaccine trials describe miserable side effects ...
Content embedded from external sources will not be displayed without your consent.
Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.
Content embedded from external sources will not be displayed without your consent.
Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.
Cyclic nuclear fusion with single-cycle, charged cathode
Abstract
A controlled fusion process is provided that can produce a sustained series of fusion reactions: a process that (i) uses a substantially higher reactant density of the deuterium and tritium gases by converging cationic reactants into the higher reaction density at a target cathode rather than relying on random collisions, the converging producing a substantially higher rate of fusion and energy production; (ii) uses a substantially lower input of energy to initiate the fusion; (iii) can be cycled at a substantially higher cycle frequency; (iv) has a practical heat exchange method; (v) is substantially less costly to manufacture, operate, and maintain; and, (vi) has a substantially improved reaction efficiency as a result of not mixing reactants with products.
...
Claim ...
3. The method of claim 1, wherein deuterium is both the first reactant and the second reactant.
The current COVID-19 pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) and has an enormous impact on human health and economy.
In search for therapeutic options, researchers have proposed resveratrol, a food supplement with known antiviral, anti-inflammatory and anti-oxidant properties as an advantageous antiviral therapy for SARS-CoV-2 infection.
Here, we provide evidence that both resveratrol and its metabolically more stable structural analog, pterostilbene, exhibits potent antiviral properties against SARS-CoV-2 in vitro. Resveratrol and pterostilbene showed antiviral activity in African green monkey kidney cells and in human primary bronchial epithelial cells cultured in an air-liquid interface system. Mechanistic analyses demonstrated that both compounds actively interfere with the post-entry steps of virus replication cycle and their antiviral activity is long-lasting. Collectively, our data indicate that resveratrol and pterostilbene are promising antiviral compounds to treat SARS-CoV-2 infection and advocate
evaluation of these compounds in clinical trials.
Also, a list of references exploring quercetin as a preventative and therapeutic -
Content embedded from external sources will not be displayed without your consent.
Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.
Follow up interview of Dr. Thomas Borody on ivermectin -
Professor Thomas Borody Interview – Part 2
- discusses whether randomized clinical trials are required for ivermectin
Content embedded from external sources will not be displayed without your consent.
Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.
Content embedded from external sources will not be displayed without your consent.
Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.
Lou how do these guys know their preferred treatments are effective? Seems to me without some comparison that is unbiassed (= RCT) they cannot have much evidence? I mean, almost all (99%) of early COVID patients recover. That percentage changes by 10X (e.g. 0.3% to 3%) for a change in median age from 30 to 50 etc. many other effects change it too. I'm sure you know that mortality figures vary wildly according to how many people getting milder versions of the disease are counted, how many are treated in hospital (for the hospital mortality figures), etc.
This sounds like reasonable evidence to me:
(Page 6) "Comparison with other treatments
Overall mortality rate of patients treated according to IDEA protocol was 0.59 % (1 death in 167 treated cases).
As a comparison, estimated overall mortality rate in Argentina is approximately 2.1 % (official data by September 2nd, 2020).
Regarding moderate to severe cases, i.e. patients needing hospitalization, only 1 patient out of 32 receiving IDEA treatment
died (3.1 %), whereas mortality rate published in articles from Spain, Italy and Spain is ca. 25 %. Moreover, a group of 12
patients were hospitalized in Eurnekian hospital in the same period but did not receive IDEA treatment. Three of them died,
thus presenting a mortality rate of 25 %, i.e. significantly higher than that of those receiving IDEA treatment."
Also note that the moderate-to-severe average age was nearly 60, and that they were using oxygen or ventilated.
Let's leave the doctor-patient team decide the best course, but who would want to be on the
placebo arm of an RCT? However, if they do, then they should be allowed.
Content embedded from external sources will not be displayed without your consent.
Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.
Content embedded from external sources will not be displayed without your consent.
Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.
Content embedded from external sources will not be displayed without your consent.
Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.
Lou - you keep on posting these videos, which I have no time to read and anyway from past experience have found usually contain PR, not new facts. If you can find equivalent written links it would be more helpful.
Here is the link you requested -
Hydroxychloroquine is Effective and Safe for the Treatment of COVID-19, and May be Universally Effective When Used Early Before Hospitalization: A Systematic Review
Content embedded from external sources will not be displayed without your consent.
Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.
